Chandan Healthcare IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details

Chandan Healthcare IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE & RoNW
The Company Key Performance Indicates the pre-issue EPS of ₹ 8.14 and post-issue EPS of ₹ 6.66 for FY24. The pre-issue P/E ratio is 19.53x, while the post-issue P/E ratio is 23.89x against the Industry P/E ratio is 75x. The company's ROCE for FY24 is 35.20%, ROE for FY24 is 47.50% and RoNW 39.54%. The Annualised EPS based on the latest financial data is ₹ 10.76 and PE ratio is 14.77x. These metrics suggest that the IPO is fairly priced.

Key Performance Indicator

KPI Values
EPS Pre IPO (Rs.) ₹8.14
EPS Post IPO (Rs.) ₹6.66
P/E Pre IPO 19.53
P/E Post IPO 23.89
ROE 47.50%
ROCE 35.20%
P/BV 3.42
Debt/Equity 1.02
RoNW 39.54%

Services

Services

onlyfans leakedonlyfan leaksonlyfans leaked videos